MENU
+Compare
ALVO
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$8.72
Change
-$0.03 (-0.34%)
Capitalization
2.72B

ALVO Alvotech Forecast, Technical & Fundamental Analysis

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more

ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALVO with price predictions
Oct 17, 2025

ALVO in -2.90% downward trend, declining for three consecutive days on October 17, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ALVO declined for three days, in of 262 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

ALVO broke above its upper Bollinger Band on October 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ALVO entered a downward trend on September 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2025. You may want to consider a long position or call options on ALVO as a result. In of 110 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ALVO just turned positive on October 14, 2025. Looking at past instances where ALVO's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

ALVO moved above its 50-day moving average on October 14, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ALVO crossed bullishly above the 50-day moving average on October 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ALVO advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (17.681). P/E Ratio (37.913) is within average values for comparable stocks, (72.923). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.078). ALVO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (4.440) is also within normal values, averaging (46.505).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALVO is expected to report earnings to fall 104.52% to -2 cents per share on November 12

Alvotech ALVO Stock Earnings Reports
Q3'25
Est.
$-0.02
Q2'25
Beat
by $0.50
Q1'25
Beat
by $0.32
Q4'24
Missed
by $0.15
Q3'24
Beat
by $0.03
The last earnings report on August 13 showed earnings per share of 50 cents, beating the estimate of 0 cents. With 314.43K shares outstanding, the current market capitalization sits at 2.72B.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDLX15.660.10
+0.64%
Artisan Value Advisor
LIFLX15.700.09
+0.58%
Lord Abbett Focused Large Cap Value I
AGVFX27.81N/A
N/A
American Funds Global Insight A
FHJUX45.93-0.22
-0.48%
Fidelity Advisor Europe A
MMUGX26.27-0.14
-0.53%
MFS Utilities R1

ALVO and Stocks

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-0.34%
EBS - ALVO
24%
Poorly correlated
-2.55%
CRON - ALVO
23%
Poorly correlated
+0.40%
ACB - ALVO
22%
Poorly correlated
-0.95%
PBH - ALVO
21%
Poorly correlated
+0.45%
PAHC - ALVO
21%
Poorly correlated
+2.98%
More

Groups containing ALVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-0.34%
Pharmaceuticals: Generic
industry (219 stocks)
26%
Poorly correlated
-0.27%